Innovative Methods of Treating Cancer

How Eric Lefkofsky Has Revolutionized Cancer Treatment

Due to changing lifestyles, incidences of cancer have been on the rise. The current efforts to provide a lasting solution for the condition have been insufficient. More than forty per cent of adults in America will have a cancer diagnosis at one point in their lives. Needless to say, cancer is always a terrible disease. The effects of the disease on a loved one can be quite devastating. Due to the concerted efforts of some people, the prognosis of the conditions appears to be improving. Indeed, Tempus is a company that has been in the forefront seeking to develop innovative methods of dealing with the condition. It is important to note that the company was co founded by Eric Lefkofsky and more information click here.

The main aim of the company is to lead the front in developing data enabled precision treatments. With the development of such technology, treating patients will become quite simpler. In the recent past, there have been efforts to develop electronic health records. However, the efforts have not been sufficient to stem the tide of cancer. Eric Lefkofsky developed some interest in the treatment of cancer when his wife was diagnosed with breast cancer. His personal experience increased his commitment to deal with the condition head on and learn more about Eric.

Before the diagnosis of his wife, Eric Lefkofsky had never come face to face with the condition. In the course of the treatment of his wife, he realized that there were numerous gaps in the methods used in treating the condition. For instance, he realized that most hospitals were lagging behind with respect to data collection when treating cancer patients. Most hospitals were also lagging behind with respect to the kind of digital technology used in treating the condition.

Eric Lefkofsky co founded tempus with a view to improving the quality of human life. The operating system that Tempus has developed has gone a long way in helping doctors to deal with cancer. According to many experts, the treatment of cancer lies in the use of disruptive technologies. Where coming up with lasting solutions, Eric Lefkofsky has hired a dedicated staff. For instance, Kevin has played a crucial role in helping Eric manage Tempus and Eric’s lacrosse camp.

More Visit: http://lefkofskyfoundation.com/about-eric-lefkofsky/

Luiz Carlos Trabuco Cappi Looks To Fill Big Shoes Of His Predecessor

There are few corporate success stories in Brazil as compelling as both those of Bradesco and its CEO, Luiz Carlos Trabuco Cappi. Both man and company rose in lock step with each other, from the obscurity of a small town in Central Sao Paolo the the upper echelons of the global financial world. But now that Bradesco, by some measures, the largest financial institution in Brazil, is run by Trabuco Cappi, questions remain as to how the expert banker will be able to fill the formidable shoes of his predecessor.

A meteoric rise

In 2009, Trabuco Cappi inherited a company that was at its zenith when he was appointed CEO. The former CEO, Mario Cypriano, had succeeded at growing the company faster than any other financial institution in the country. He had grown the bank from a relatively modest concern of just $5 billion in assets to well over $100 billion in just under a decade. During that time, the stock price had increased by a jaw-dropping 200 percent, and the bank had successfully grown all of its product lines, both organically and through the use of strategic acquisitions. By 2009, Bradesco was the second largest bank in Brazil, just behind its main rival Itau Unibanco.

However, just as Luiz Carlos Trabuco Cappi took the reins, things were beginning to change in the Brazilian financial space and not for the better. The country’s economy entered into a slump, and it seemed that additional organic growth in banking, insurance and financial services would be difficult to come by. At the same time, the consolidation craze that had swept the country’s banking industry over the 2000s was petering out, not for lack of appetite for acquisitions but because there simply were no suitable targeted left that had not already been acquired. All of this promised to present major barriers to Bradesco’s continued growth into the future.

Even amid relatively low expectations, Trabuco Cappi’s tenure proved to be a bit of a disappointment, at least for the first 6 years. While the bank held its own amid a hyper-competitive environment, there were no gains in the stock price and many of Trabuco Cappi’s own stated goals failed to materialize. It looked as if the reign of the man that many experts had heralded as the most experienced and knowledgeable banker ever to operate in the country would turn out to be a bust.

But then, in 2015, rumors started to fly that HSBC Brazil, one of the largest financial holding companies in the country, was seeking to divest all of its assets. The firm had been experiencing losses, year over year, for enough time that it was ready to throw in the towel. It no longer wished to dedicate valuable managerial talent and commit resources to operating in the tough Brazilian market. Trabuco Cappi began talks with its management.

By the end of 2015, it became clear that Bradesco would purchase HSBC outright for $5.2 billion in cash, the single largest business transaction in the history of Brazil. The deal closed, making Trabuco Cappi the talk of the Brazilian financial press. He was awarded the Isto E Dinheiro 2015 Entrepreneur of the Year award and was widely lauded for his skill in spotting and completing the deal. All told, the deal boosted Bradesco’s total assets to more than $400 billion, making it the second largest bank in the country in terms of assets. For the first time, the bank also became the largest in Brazil when measured by account holders, funds under management and loans extended. The deal was widely considered a coup for Bradesco.

But the real prize in all of this may be the fact that Bradesco is now positioned to take a decisive lead in the Brazilian financial sector. Whether or not Trabuco Cappi will be able to capitalize on this new found position of strength has yet to be seen. But his track record is promising.

Eric Lefkofsky: The Entrepreneur Operating on Cancer in a Novel Way

Eric Lefkofsky is a man of many trades, but his next venture, Tempus, may be his most ambitious project to date. Tempus is a technology company seeking to revolutionize the way cancer is operated on. In fact, Tempus is seeking to do so through a computer operating system. In 2014 there were 14.5 million US adults diagnosed with cancer and that number is expected to increase to 19 million by 2024. Tempus is attempting to address this growing need specifically through clinical data management. Their approach is two-fold. Firstly, Tempus developed software that captures and analyzes a physician’s progress note and codes it into structured data points. Secondly, these clinical data points are then coupled with molecular data from the human genomic sequencing database. By pairing these two distinct sources of data, researchers will be able to evaluate what variables influence the efficacy of cancer treatments in specific patients. In other words, physicians will now have a growing repository of information, that can be updated in real-time, to help a them pick the the best treatment option for individual patients. With such innovative thinking, Tempus has positioned itself at the forefront of the precision-medicine movement and may eventually be able to apply its platform to additional disease states in the future and learn more about Eric.

Eric Lefkofsky is most well known as the co-founder of Groupon, and now also as the co-founder of Tempus. As an undergraduate, he attended the University of Michigan, where he also went on to earn his Juris Doctor degree from the University of Michigan Law School. Lefkofsky has also had an illustrious professorial career with positions at Kellstadt Graduate School of Business, Kellogg School of Management, and the Booth School of Business and Eric’s lacrosse camp.

Additionally, Lefkofsky proudly serves on the board of directors for a number of organizations including the Lurie’s Children’s Memorial Hospital in Chicago, the Art Institute of Chicago, and also serves as the Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company.

More Visit: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/